已更新
RAD - DAILY CHART
Hi, today we are going to talk about Rite Aid and its current landscape.
Rite Aid is poised to receive increasing attention from the market as relevant events are taking place. The American drugstore chain issued better than expected EPS, and sales results for its third-quarter report also raised its fiscal-year EPS guidance above estimates. Positive news that can be attributed to the company's efforts to deploy its new strategy, which includes investment into its pharmacy benefit manager.
Thank you for reading and leave your comments if you like.
To have access to our exclusive contents, join the Traders Heaven today! Link Below.
Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice.
Rite Aid is poised to receive increasing attention from the market as relevant events are taking place. The American drugstore chain issued better than expected EPS, and sales results for its third-quarter report also raised its fiscal-year EPS guidance above estimates. Positive news that can be attributed to the company's efforts to deploy its new strategy, which includes investment into its pharmacy benefit manager.
Thank you for reading and leave your comments if you like.
To have access to our exclusive contents, join the Traders Heaven today! Link Below.
Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice.
註釋
target 1 and 2 reached!
Igor Silva · análise técnica e sistemas quantitativos
▎ TraderLab — cursos, indicadores e execução com disciplina · traderlab.finfocus.com.br/
▎ TraderLab — cursos, indicadores e execução com disciplina · traderlab.finfocus.com.br/
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。
Igor Silva · análise técnica e sistemas quantitativos
▎ TraderLab — cursos, indicadores e execução com disciplina · traderlab.finfocus.com.br/
▎ TraderLab — cursos, indicadores e execução com disciplina · traderlab.finfocus.com.br/
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。